Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Abdulkareem, Alsuwaida"'
Autor:
Fayez AlHejaili, Muhammad N. Hashmi, Abdulkareem Alsuwaida, Ghada A. Ankawi, Shahad A. ALMehaideb, Anas A. Alsuwaida, Mohammed T. AlZahrani, Ali E. Shehadah, Hatem A. AlNasser
Publikováno v:
Avicenna Journal of Medicine, Vol 14, Iss 02, Pp 110-114 (2024)
Background Understanding the factors that contribute to unemployment will help in the design of creative resolutions to enable hemodialysis patients to return to a productive life.
Externí odkaz:
https://doaj.org/article/1f55c14270574939a117a69c7ba81075
Autor:
Aamer Aleem, Abdulrahman Al-Sultan, Abdulkareem Alsuwaida, Khalid Alsaleh, Farjah Algahtani, Abdulkareem Almomen, Mohammad Sharif, Ghazi S. Alotaibi
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 34, Iss 6, Pp 531-536 (2023)
Proteinuria is a manifestation of sickle cell anemia (SCA)-related renal disease and is a risk factor of renal impairment. Angiotensin-converting enzyme (ACE) inhibitors have benefits, but their role in SCA remains undefined. This study aimed to asse
Externí odkaz:
https://doaj.org/article/10f30118f24848599ea88d1ddef77c61
Autor:
Talal AlFaadhel, Abdulkareem Alsuwaida, Khaled Alsaad, Lamees Almezaini, Noura Ahmed, Mahmoud Yassin AlHamad, Ammar Bakheet, Junaid Wadera, Ghadeer Mokhtar, Feras Alsuwaida, Rehan Siddiqui, Mohamed Kechrid, Ashraf Abdelrehman, Sufia Husain, Hala Kfoury, Abdulrahaman Alabdulsalam, Majed Alanazi, Noura Al Oudah, Hanadi AlHozali
Publikováno v:
Annals of Saudi Medicine, Vol 39, Iss 3, Pp 155-161 (2019)
BACKGROUND: Recent international reports have shown significant changes in the incidence of different glomerular diseases. OBJECTIVE: Examine temporal and demographic trends of biopsy-diagnosed glomerular diseases in the adult population of Saudi Ara
Externí odkaz:
https://doaj.org/article/b6a7273e374a430a9aa10cbd630821ed
Autor:
Maciej Drozdz, André Weigert, Fatima Silva, João Frazão, Abdulkareem Alsuwaida, Mahesh Krishnan, Werner Kleophas, Szymon Brzosko, Fredrik K. Johansson, Stefan H. Jacobson
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background The optimal treatment algorithm for iron therapy and the use of erythropoiesis-stimulating agents (ESA) in anemic hemodialysis (HD) patients has not been established. Hemoglobin (Hb) target levels can be achieved through more freq
Externí odkaz:
https://doaj.org/article/46ee3a6595204fd482ba9f73592961cd
Autor:
Saeed Al-Ghamdi, Ali Abu-Alfa, Turki Alotaibi, Ali AlSaaidi, Abdulkareem AlSuwaida, Mustafa Arici, Tevfik Ecder, Ahmed F El Koraie, Mohamed Ghnaimat, Mohamed H Hafez, Mohamed Hassan, Tarik Sqalli
Publikováno v:
International Journal of Nephrology and Renovascular Disease. 16:103-112
Autor:
Abdulkareem Alsuwaida, Sufia Husain, Mohammed Al Ghonaim, Noura Aloudah, Anhar Ullah, Hala Kfoury
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 27, Iss 2, Pp 305-311 (2016)
Lupus nephritis (LN) is characterized by a highly variable clinical course. It has been reported that histopathologic lesions are risk factors for the progression of LN. The aim of this study is to investigate the relationship among the co-deposition
Externí odkaz:
https://doaj.org/article/7d231c0710a04849b5b680ba6533714f
Autor:
Muhammad Ziad Souqiyyeh, Faissal A. M. Shaheen, Abdulkareem Alsuwaida, Mohammed Alghonaim, Jamal Alwakeel, Dujana Mosa, Faheem Akhtar, Ebadur Rahman, Maged Hussein, Hysam Roujouleh, Nauman Siddiqi, Ibtissam Bukhari, Nihal Sadaqa, Faissal Mushtaque, Neveen Mustafa Awn, Fouad Shariya, Adnan Alfi, Mohammad Amin, Mustafa Ahmad, Fadel Abbas Rowaie, Samir Almueilo, Mohamed Chihab Eddine Kechrid, Ayman Karkar
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 26, Iss 1, Pp 47-55 (2015)
To evaluate the use of rituximab in the treatment of severe glomerulonephritis (GN) in order to prevent progression of kidney disease toward the end stage, we designed a multicenter, retrospective study in Saudi Arabia about the efficacy and safety o
Externí odkaz:
https://doaj.org/article/545c6679c18044ed92b8b2372748932b
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 25, Iss 5, Pp 981-985 (2014)
Peritoneal dialysis (PD) patients have a high risk of developing vitamin D deficiency as 25(OH) vitamin D, the precursor of active vitamin D, is lost during dialysis. This crosssectional study was conducted to investigate the prevalence of vitamin D
Externí odkaz:
https://doaj.org/article/490f9c54220448f6bc7ff7820f0beef2
Autor:
Ahmad Mitwalli, Abdulkareem Alsuwaida, Jamal Al Wakeel, Saira Usama, Nouf Zainalddain, Mohammed Al Ghonaim, Durdana Hammad
Publikováno v:
Annals of Saudi Medicine, Vol 33, Iss 5, Pp 457-463 (2013)
BACKGROUND AND OBJECTIVES: To evaluate differences in erythropoietin requirements between diabetic and non-diabetic patients on hemodialysis and peritoneal dialysis. DESIGN AND SETTINGS: This was a retrospective, cross-sectional study conducted betwe
Externí odkaz:
https://doaj.org/article/82f6a0627dff465984e3843cf66f8b21
Autor:
Tarek M Demerdash, Abdullah Kashgary, Abdulkareem Alsuwaida, Mostafa Abdelsalam, Hany Alanany, Mahmoud M Shaheen, Mohammed Assem, Muhammad Awais, Ayman Sabri
Publikováno v:
Therapeutic Apheresis and Dialysis. 25:483-489
Hemodiafiltration (HDF) is not associated with lower mortality risk compared to standard hemodialysis (HD). However, there are many critical clinical outcomes in dialysis patients in addition to mortality; the impact of HDF on these other outcomes is